Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

NCT00247494 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
Atherosclerosis

Interventions

DRUG: mycophenol mofetil (MMF, Cellcept®) 500 mg BID

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)